Annual Cash & Cash Equivalents
$739.00 K
+$56.10 K+8.21%
December 31, 2023
Summary
- As of February 7, 2025, MGRX annual cash & cash equivalents is $739.00 thousand, with the most recent change of +$56.10 thousand (+8.21%) on December 31, 2023.
- During the last 3 years, MGRX annual cash & cash equivalents has risen by +$716.40 thousand (+3169.91%).
- MGRX annual cash & cash equivalents is now at all-time high.
Performance
MGRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$73.90 K
-$416.30 K-84.92%
September 1, 2024
Summary
- As of February 7, 2025, MGRX quarterly cash and cash equivalents is $73.90 thousand, with the most recent change of -$416.30 thousand (-84.92%) on September 1, 2024.
- Over the past year, MGRX quarterly cash and cash equivalents has dropped by -$1.16 million (-94.02%).
- MGRX quarterly cash and cash equivalents is now -98.05% below its all-time high of $3.79 million, reached on March 31, 2023.
Performance
MGRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MGRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.2% | -94.0% |
| 3 y3 years | +3169.9% | -94.0% |
| 5 y5 years | +3169.9% | -94.0% |
MGRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3169.9% | -98.0% | +383.0% |
| 5 y | 5-year | at high | +3169.9% | -98.0% | +383.0% |
| alltime | all time | at high | +3169.9% | -98.0% | +383.0% |
Mangoceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $73.90 K(-84.9%) |
| Jun 2024 | - | $490.20 K(+3103.9%) |
| Mar 2024 | - | $15.30 K(-97.9%) |
| Dec 2023 | $739.00 K | $739.00 K(-40.2%) |
| Sep 2023 | - | $1.24 M(-58.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $2.95 M(-22.3%) |
| Mar 2023 | - | $3.79 M(+455.2%) |
| Dec 2022 | $682.90 K(+2921.7%) | $682.90 K(-21.8%) |
| Sep 2022 | - | $873.50 K |
| Dec 2021 | $22.60 K | - |
FAQ
- What is Mangoceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Mangoceuticals?
- What is Mangoceuticals annual cash & cash equivalents year-on-year change?
- What is Mangoceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Mangoceuticals?
- What is Mangoceuticals quarterly cash and cash equivalents year-on-year change?
What is Mangoceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of MGRX is $739.00 K
What is the all time high annual cash & cash equivalents for Mangoceuticals?
Mangoceuticals all-time high annual cash & cash equivalents is $739.00 K
What is Mangoceuticals annual cash & cash equivalents year-on-year change?
Over the past year, MGRX annual cash & cash equivalents has changed by +$56.10 K (+8.21%)
What is Mangoceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MGRX is $73.90 K
What is the all time high quarterly cash and cash equivalents for Mangoceuticals?
Mangoceuticals all-time high quarterly cash and cash equivalents is $3.79 M
What is Mangoceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, MGRX quarterly cash and cash equivalents has changed by -$1.16 M (-94.02%)